Controlled release drug delivery system of cardiovascular drug

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2014, Vol 2, Issue 10

Abstract

Conventional medication systems that require multi-dose therapy are with problems. With a view to overcome these problems, the current trend in pharmaceutical research is to design and develop new formulations, thereby enhancing the therapeutic efficacy of existing drugs. Controlled release (CR) technology has rapidly emerged over the past three decades as a new interdisciplinary science that offers novel approaches to the delivery of bioactive agents into systemic circulation at a predetermined rate. The choice of drug to be delivered, clinical needs, and drug pharmacokinetics are some of the important considerations in the development of controlled release formulation, in additions to the relation between the rates of drug release from the delivery system to the maximum achievable rate of drug absorption into the systemic circulation. By gaining, a premonation and reproduce bioactive agent release rate for an extended period of time, controlled release formulation can achieve optimum, long time efficacy, minimised toxicity and therapeutic potent responses. Controlled release pellets are manufactured either to deliver the bioactive agent at a specific site within the gastrointestinal tract or to sustain the action of drugs over an extended time period. Since these results have been achieved through the application of a functional coating materials at times the core pellets themselves have been modified to provide the desired effect.

Authors and Affiliations

Rajesh Asija*| Department of pharmaceutics, Maharishi Arvind institute of pharmacy, Mansarovar, Jaipur-302020, Rajasthan, India, Sangeeta Asija| Department of pharmaceutics, Maharishi Arvind institute of pharmacy, Mansarovar, Jaipur-302020, Rajasthan, India, Arvind Mehta| Department of pharmaceutics, Maharishi Arvind institute of pharmacy, Mansarovar, Jaipur-302020, Rajasthan, India

Keywords

Related Articles

INDUSTRIAL PROCESS VALIDATION: A REVIEW

Validation is defined in the supplementary information section of the Federal Register as “a QA function that helps ensure drug product quality by providing documented evidence that the manufacturing process consistentl...

Pharmacognostical and pharmacological evaluation of the leaf of Gmelina Arborea Roxb

Gmelina Arborea Roxb. (Verbenaceae ) is commonly known as gambhari. Gambhari is one of the herbs mentioned in all ancient scriptures of Ayurveda, as one of the member of brhat pancamulas. Acarya Vagbhata has cited gambha...

Unilateral Spinal Anaesthesia For Toilet Mastectomy-As An Alternative To General Anaesthesia: A Case Report

General anaesthesia is a choice of anaesthesia for surgeries of breast like modified radical mastectomy (MRM). But patients with lung disease like bronchial asthma, COPD, poor pulmonary function are at a high risk for pe...

An open label observational study for Drug adherence in Type 2 Diabetes Mellitus patients

Diabetes mellitus is a heterogeneous group of disorders characterized by abnormalities in carbohydrate, protein, and lipid metabolism. The central disturbance in diabetes mellitus is an abnormality in insulin production...

Pharmacovigilance in psychiatry: time to take notice

The term ‘Pharmacovigilance’ is used to describe the activities that are related to monitoring adverse drug reactions (ADRs). The World Health Organization (WHO) defines it as “the science and activities relat...

Download PDF file
  • EP ID EP1546
  • DOI -
  • Views 397
  • Downloads 38

How To Cite

Rajesh Asija*, Sangeeta Asija, Arvind Mehta (2014). Controlled release drug delivery system of cardiovascular drug. Journal of Drug Discovery and Therapeutics, 2(10), 25-30. https://www.europub.co.uk/articles/-A-1546